-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 8, 2021, Amgen and AstraZeneca jointly announced that the U.
The BLA is based on the results of a clinical trial called PATHFINDER, including the results of the pivotal phase 3 trial NAVIGATOR.
Tezepelumab is a potential "first-in-class" drug that blocks the effects of thymic stromal lymphopoietin (TSLP)